BIOG_B: Sales fell 4% as EMEA lagged, but Asia Pacific and Americas posted strong growth

About this update from Biogaia Ab Class B

Q3 saw a 4% sales decline, mainly from EMEA, while Asia Pacific and Americas grew. EBIT dropped 65% due to a SEK 51.2 million impairment, but adjusted EBIT margin was 31%. Direct markets and new product launches are driving future growth, with strong momentum in Asia and the U.S.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Biogaia Ab Class B